Kaimax is an original strain developed by the European National Institute and is a high-purity product that carries a low risk of immunogenicity. It conforms to cGMP standards set by the FDA and EMA for safe and effective skin and wrinkle improvement as well as larger muscle treatments.
Kaimax is the original botulinum toxin strain from the European National Institute and is a high purity product with low immunogenicity risk, compliant with cGMP (FDA, EMA) st..
Kaimax is the original botulinum toxin strain from the European National Institute and is a high purity product with low immunogenicity risk, compliant with cGMP (FDA, EMA) st..